Phase I Dose Escalation Trial of Biweekly Alimta (With Vitamin Supplementation) in Combination With Taxotere in Advanced Solid Tumor Patients.
Phase of Trial: Phase I
Latest Information Update: 09 Dec 2015
At a glance
- Drugs Docetaxel (Primary) ; Pemetrexed (Primary)
- Indications Breast cancer; Gastric cancer; Head and neck cancer; Non-small cell lung cancer; Oesophageal cancer; Ovarian cancer; Prostate cancer; Solid tumours
- Focus Adverse reactions
- 02 Dec 2015 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov.
- 03 Jun 2014 Interim results presented at the 50th Annual Meeting of the American Society of Clinical Oncology.
- 12 Aug 2010 New trial record